Biohaven Ltd
BHVN
Market Cap$2.07B
Close$
$0.69
96.6% downside
Current Fair Value
96.6% downsideOvervalued by 96.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.07 Billion |
|---|---|
| Enterprise Value | $2.00 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-9.28 |
| Beta | 4.18 |
| Outstanding Shares | 101,054,895 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.42 |
|---|---|
| PEG | -4.29 |
| Price to Sales | - |
| Price to Book Ratio | 5.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.36 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biohaven Pharmaceutical Holding Company Ltd
CEO: Vlad Coric